PCK

3.23%

3.0¢ painchek ltd

Ann: Update on PainChek Business Performance, page-110

First 110 Last

Share
Profile

Follow
PerryNuym

388 Posts.

78

24/12/19

07:56

Post #: 42112456
Share

Originally posted by kenjikool: ↑

"I am interested in the price as well as other company metrics, and I am curious about the factors that created this price and when it will change, regardless of Painchek’s long term potential".

Totally agree, I would love to know how the market has priced this. The reason my posts have become infrequent is that I am no longer trading PCK. Too many times I have bought and sold stocks that i like and did my DD on to see good gains but if i sat on them, would have made me rich .

I need to spend more of my time researching others, as I now feel very confident on parking a large amount of my capital in PCK. Not sure what it is with P's but they have been very Kind to me. Maybe as it's the first letter of my real last name?

But the main reason to respond to your post is that i have no idea what the market is doing with PCK. I've stopped trying to understand it, so no trading. One minute it's happy to count in future revenue, the next it wants to see $$$. Friday jumps with no news, Wed drop on good news. Sell the news? Well there's been a lot better opportunities recently to do this. The sell of the directors shares was a biggy. But I can see why they needed to do this. I see it the same way as Scomo going on holidays when the fires were happening. Well, he's worked hard all year surely the guy gets to have a break right? Directors have made me, and a lot of others some very good money, surely they get to take some off the table? Anyway enough of my midnight ramblings, I think I need to go cuddle my wife or something, right Perry and Mumsya?

Expand

you have good break Ken
look after family
sp look after itself , zero doubt
2020 our year to watch our baby grow
dyor imo
rocket ship

PCK Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 35 more messages in this thread...

First 110 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change -0.001(3.23%)		Mkt cap ! $49.11M

Open	High	Low	Value	Volume
3.0¢	3.0¢	3.0¢	$12.08K	402.6K

Buyers (Bids)

No.	Vol.	Price($)
8	305189	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	99999	1

View Market Depth

No.	Vol.	Price($)
8	305189	0.030
5	6607448	0.029
1	350000	0.028
3	488344	0.027
4	1600000	0.026

Price($)	Vol.	No.
0.031	99999	1
0.032	102605	2
0.033	126161	2
0.034	79638	2
0.035	125000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PCK (ASX) Chart

Ann: Update on PainChek Business Performance, page-110

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Update on PainChek Business Performance, page-110

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News